stephen cavell |
👍
2
Mon 2 Sep, 06:59 Thanks for those responses and on the 6.30 Radio 4 news I have just had it all confirmed. A new vaccine aimed at specific cohorts. Well done to CMC for being ahead of the curve. |
Robin Taylor |
👍
1
Sun 1 Sep, 14:35 And a balancing act for those who have turned 80, it’s felt they have a poorer response to making antibodies from the jab, and a higher risk of side effects, so they are currently excluded. |
Christine Battersby |
👍
2
Sun 1 Sep, 14:09 It's a different vaccination, Stephen, but an old ailment -- the type of cough or cold (respiratory virus) that can lead to pneumonia in the elderly or those with a weakened immune system, as well as bronchiolotis (in young infants). The new type of RSV jab was introduced in the US in May 2023, and the side effects are still being closely monitored. So it is at first only being offered to those at highest risk. A kind of balancing act, where the likely benefits are judged to outweigh the potential harms. Hence the over 75 age limit, plus also some pregnant women to protect their their babies for the first few months after birth. |
sharon |
👍
Sun 1 Sep, 14:01 As I believe the pneumococcal vaccine is for pneumonia as I have had it but as for the RSV vaccine I always was lead to believe that only children under 2 got RSV |
stephen cavell |
👍
2
Sun 1 Sep, 11:56 This is the first I have ever heard of this RSV virus and although I note my age group is excluded from vaccination - please enlighten me. I received a vaccination some 15 years ago - invitation headed at the time 'Pneumococcal Vaccination'. Is it the same virus. I would hate to think there is a malady lurking round the corner I am not protected against. |
You must log in before you can post a reply.